NCT00130117View on ClinicalTrials.gov

Study of Leptin for the Treatment of Hypothalamic Amenorrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2016

Conditions
Amenorrhea
Interventions
DRUG

r-metHuLeptin

Starting dose: 0.08mg/kg once daily Subcutaneous injection.

DRUG

Oral Contraceptive Pills (OCPs)

Sprintec taken orally once daily.

OTHER

Placebo

placebo (no active medication)

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center General Clinical Research Center, Boston

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

Amgen

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER